H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Pharming Group (PHGUF – Research Report) today and set a
Tag: Joseph Pantginis
H.C. Wainwright Keeps a Buy Rating on BiomX (PHGE)
H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on BiomX (PHGE – Research Report) today and set a price
Iovance Biotherapeutics (IOVA) Receives a Rating Update from a Top Analyst
In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Hold rating on Iovance Biotherapeutics (IOVA – Research
Atreca (BCEL) Receives a Buy from H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Atreca (BCEL – Research Report) today and set a price
Caladrius Biosciences (CLBS) Gets a Buy Rating from H.C. Wainwright
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Caladrius Biosciences (CLBS – Research
Analysts Conflicted on These Healthcare Names: ESSA Pharma (NASDAQ: EPIX) and Sangamo Biosciences (NASDAQ: SGMO)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ESSA Pharma (EPIX
Kura Oncology (KURA) Gets a Buy Rating from H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Kura Oncology (KURA – Research Report) today and set a